Prophylactic Central Lymph Node Dissection Improves Disease-Free Survival in Patients with Intermediate and High Risk Differentiated Thyroid Carcinoma: A Retrospective Analysis on 399 Patients
The role of prophylactic central lymph node dissection (pCLND) in the treatment of differentiated thyroid cancer (DTC) is controversial and still a matter of debate. The primary outcome of our study was to assess whether pCLND is effective in reducing the incidence of recurrent disease, and the seco...
Main Authors: | Fabio Medas, Gian Luigi Canu, Federico Cappellacci, Giacomo Anedda, Giovanni Conzo, Enrico Erdas, Pietro Giorgio Calò |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1658 |
Similar Items
-
Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid: Retrospective Analysis on 293 Cases
by: Fabio Medas, et al.
Published: (2020-08-01) -
Location of Retroperitoneal Lymph Node Metastases in Upper Tract Urothelial Carcinoma: Results from a Prospective Lymph Node Mapping Study
by: Johannes Bobjer, et al.
Published: (2023-11-01) -
Prophylactic Central Neck Lymph Node Dissection Adds No Short-Term Benefit to Total Thyroidectomy for Differentiated Thyroid Cancer
by: Rosen Dimov, et al.
Published: (2023-01-01) -
The role of defining the sentinel lymph node in the treatment of low-risk highly differentiated thyroid cancer (review of literature)
by: M. E. Boriskova, et al.
Published: (2020-08-01) -
Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients
by: C Sui, et al.
Published: (2020-02-01)